@BorisSepesi

Thoracic Surgery, Lung Cancer, Esophageal Cancer, Mesothelioma

Joined September 2022
  • Tweets70
  • Following176
  • Followers258
3Media
Boris Sepesi MD FACS retweeted
Vala Afshar
@ValaAfshar10 Jun 2024
Life lessons from @rogerfederer (must watch) 1 Effortless is a myth 2 Belief in yourself has to be earned 3 Grit > Gift 4 Discipline is talent 5 Trust and loving the process is talent 6 You can do your best and still lose 7 Life is bigger than the court
215
6,644
569
28,326
2,760,435
I’m so proud of our @MDAndersonNews CT Surgery Jeopardy finalists, Drs @KGMitchellMD and @DavidNelsonMD! Come cheer for them in the exhibit hall this morning! @TSRA_official @ThoracicStudent #STS2023
3
34
2,893
I am one proud program director today! Our @MDAndersonNews thoracic surgery fellows, Drs @KGMitchellMD and @DavidNelsonMD won the CTSurgery showdown championship today! I’m so happy that the final jeopardy was “who was lariche?” #STS2023 @STS_CTsurgery en.wikipedia.org/wiki/Ren%C3… – at Bellaire, TX
2
8
2
109
18,528
Boris Sepesi MD FACS retweeted
Eric K. Singhi, MD@lungoncdoc19 Dec 2022
🎉 12 days till 2023 ‼️ Quick 2022 snapshot review of @FDAOncology treatment approvals for our patients with lung cancer 👇🏽 #lcsm #lungcancer @OncoAlert
1
30
2
78
13,735
Boris Sepesi MD FACS retweeted
Vivek Subbiah, MD
@VivekSubbiah10 Dec 2022
⭐️Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors @NaturePortfolio nature.com/articles/s41698-0…
43
1
102
Boris Sepesi MD FACS retweeted
Brendon Stiles@BrendonStilesMD18 Nov 2022
Indeed. Complete response from crowd who loved and benefited from the tag team talk!
Balazs Halmos
@BalazsHalmosMD18 Nov 2022
I love neoadjuvant approaches- we just took 3 cycles of neoadjuvant drinks with @NickRohsMD prior to a talk and i thought we really improved the response! @BrendonStilesMD
3
12
To all thoracic surgeons: Have faith in your #medonc colleagues and witness the impact of neoadj chemoIO on QOL! @STS_CTsurgery @AATSHQ @thoracic @ThoracicsCanada @EnriquetaFelip @SBroderickMD @BorisSepesi @maraantonoff @ekslim @BrendonStilesMD @ElliotServaisMD @ASCOPost @myESMO
2
2
1
42
Boris Sepesi MD FACS retweeted
Sam Sater, MD@HSaterMD11 Nov 2022
Dr Tina Cascone @MDAndersonNews presented an amazing review of NIO in lung cancer #LCSM and highlighted NeoCoast Study. She also called for reverse translation @sitcancer #SITC22 – at Boston, MA
5
14
Boris Sepesi MD FACS retweeted
AATS Journals@AATSJournals4 Nov 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with #NSCLC. Read the full #JTCVS article by @BorisSepesi, Cascone, et al: doi.org/10.1016/j.jtcvs.2022… @tssmn @nicolaszhoudo @rjmehran @maraantonoff @mvnegrao @AnneTsao2 @AraVaporciyan @sgswisher
Clavien-Dindo classification 1 = deviation from normal postoperative course without the need for intervention; 2 = complication requiring pharmacological intervention including blood transfusion; 3 = complication requiring invasive intervention; 4 = complication requiring intensive care unit care; and 5 - death. NEOSTAR, Nivolumab With or Without Ipilimumab in Treating Patients With Previously Untreated Stage I-IIIA Non-Small Cell Lung Cancer; ICON, The Immunogenomic Profiling of NSCLC.

ALT Clavien-Dindo classification 1 = deviation from normal postoperative course without the need for intervention; 2 = complication requiring pharmacological intervention including blood transfusion; 3 = complication requiring invasive intervention; 4 = complication requiring intensive care unit care; and 5 - death. NEOSTAR, Nivolumab With or Without Ipilimumab in Treating Patients With Previously Untreated Stage I-IIIA Non-Small Cell Lung Cancer; ICON, The Immunogenomic Profiling of NSCLC.

1
9
16
Boris Sepesi MD FACS retweeted
M.Provencio@MARIANOPROVENCI3 Nov 2022
NADIM II suggests PFS, OS benefits of nivolumab + chemo in resectable NSCLC - goo.gl/alerts/8N3YPG #GoogleAlerts

NADIM II suggests PFS, OS benefits of nivolumab... | MIMS MY

Adding nivolumab to paclitaxel-carboplatin chemotherapy in the neoadjuvant setting boosted progression-free survival (PFS) and ove... | MIMS MY

mims.com
4
8
Boris Sepesi MD FACS retweeted
Balazs Halmos
@BalazsHalmosMD29 Oct 2022
Replying to @StephenVLiu @benlevylungdoc
Just adding some more arguments to appeal to an international audience😉
1
6
41
Looking forward to telling the story of why I wear pearls in the OR at GRIT tomorrow #GRIT2022 @MayoClinic @MayoClinicSurg
3
11
2
96
Boris Sepesi MD FACS retweeted
Reza Mehran, MD@rjmehran26 Oct 2022
MD Anderson was honored with the presence of Dr. David Harpole from Duke University for the @MDAndersonNews 2022 Jack A. Roth Distinguished Lecturer in the Thoracic Surgery Research. In the process he also became an honorary Texan!
8
1
39
Perioperative Therapy in Early-Stage Lung Cancer [July 28, 2022] @ADesaiMD @AnaVManana @JackWestMD @JAMAOnc Patient Page jamanetwork.com/journals/jam… #lcsm
2
10
26
Boris Sepesi MD FACS retweeted
Brendon Stiles@BrendonStilesMD20 Oct 2022
Great summary here.... ncbi.nlm.nih.gov/pmc/article…

Santiago Ramón y Cajal’s Advice for a Young Investigator

Santiago Ramón y Cajal, a mythic figure in science and recognized as the father of modern anatomy and neurobiology, was largely responsible for the modern conception of the brain. The first to...

pmc.ncbi.nlm.nih.gov
4
8
Boris Sepesi MD FACS retweeted
Brendon Stiles@BrendonStilesMD20 Oct 2022
1)The only thing in your power is preparation 2)Be suspicious of brilliance 3)Be appropriately respectful of authority, but no more 4)Balance concentration & relaxation 5)Don’t worry about what it’s good for 6)Favor independence over resources 7)Embrace scientific panglossianism
3
6
29
Boris Sepesi MD FACS retweeted
Jose Ramos Vivas
@joseramosvivas15 Oct 2022
#PeerReview
1
24
6
81
Boris Sepesi MD FACS retweeted
TED Talks
@TEDTalks10 Oct 2022
When you stop being a jerk to yourself, you won't be the only one who benefits — *all* of your relationships will too! Watch the full talk from Dan Harris (@danbharris) here: t.ted.com/sQDWeid #WorldMentalHealthDay

How to Improve Your Life Through Self-Love

As an ABC News anchor, a panic attack led Dan Harris to become a meditator guru — and less of a jerk. In a talk, he explains how self-love meditation can boost strength and quiet your inner critic.

9
66
11
266
Boris Sepesi MD FACS retweeted
Jonathan Spicer MD PhD
@DoctorJSpicer8 Oct 2022
Adjuvant atezo in my mind is for incidental pathological stage II or III disease w/ PDL1>50% found post resection in patients fit enough to get adjuvant chemo. Patients with clinically evident stage II or III resectable disease should be oriented to neoadj chemo-nivo.
Sandip Patel MD FASCO@PatelOncology8 Oct 2022
Replying to @DrewMoghanaki @DrJNaidoo @JackWestMD @OncoAlert @DasMillie11
The interim analysis for OS from IMP010 for PD-L1>50% is quite robust and we can have confidence in offering atezo here. For PD-L1 1-49% it’s not clear the benefit and I find CM816 with 3 cycles of chemo+nivo reasonable there as we await updated survival data
3
10
1
46
Boris Sepesi MD FACS retweeted
Patrick Forde@FordePatrick4 Oct 2022
Interesting, immunotherapy first is better than targeted therapy for BRAF V600 melanoma. I would not be surprised if the same were true in BRAF V600 lung cancer. lombardi.georgetown.edu/news…

Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted...

The findings, coupled with results from another recent clinical trial, mark significant advances in the treatment of melanoma. WASHINGTON (September 27, 2022) — A clinical trial led by clinicians at...

lombardi.georgetown.edu
7
17
72
Load more